GAAP and non - GAAP measures

Search documents
QuinStreet, Inc. (QNST) Q3 2025 Earnings Conference Call Transcript
Seeking Alphaยท 2025-05-08 00:59
Core Viewpoint - QuinStreet, Inc. reported its fiscal third quarter 2025 financial results during a conference call, highlighting key financial metrics and future outlook [1][2]. Financial Results - The company discussed both GAAP and non-GAAP financial measures, with a reconciliation provided in the earnings press release available on their Investor Relations website [4]. Conference Call Participants - The conference call included key participants such as the CEO Doug Valenti and CFO Greg Wong, along with analysts from various research firms [1][2]. Forward-Looking Statements - The discussion included forward-looking statements that involve risks and uncertainties, with a reminder that actual results may differ from projections [3].
Valens Semiconductor .(VLN) - 2025 Q1 - Earnings Call Presentation
2025-05-07 11:14
Company Overview - Valens Semiconductor is a fabless semiconductor company listed on NYSE under the ticker VLN[13] - The company reported revenues of over $40 million in Q1 2025[13] - Valens has accumulated over $0.5 billion in cumulative R&D expenses[13] Financial Performance & Goals - Valens' revenue for 2024 was $57.9 million, with $36.3 million from Cross-Industry Business and $21.6 million from Automotive[68] - Q1 2025 revenue reached $16.8 million, with a GAAP gross margin of 62.9%[71] - The company is targeting revenue between $220 million and $300 million by 2029, with a CAGR of approximately 30%-40%[75] - Valens anticipates revenue between $71 million and $76 million for 2025, representing a year-over-year growth of approximately 23%-31%[76] Market Opportunities - The automotive market presents a $4.5 billion TAM by 2029, requiring 1.4 billion chips per year[25, 45] - The video conferencing market has a TAM of $350 million by 2028/29, needing approximately 17 million chips per year[25, 31] - The industrial/machine vision market is projected to reach a TAM of $460 million by 2028/29, with a demand for approximately 32 million chips per year[25, 53] - The single-use medical market represents a $625 million TAM, requiring 125 million chips per year[25, 57]